| Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer | Alex Lash | 12/08/14 | National |
| TX Roundup: Need, Experiment Engine, Bigcommerce, Bellicum, CS Disco | Angela Shah | 12/02/14 | Texas |
| Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO | Angela Shah | 11/19/14 | Texas |
| Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment | Angela Shah | 08/27/14 | Texas |
| Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration | Bruce V. Bigelow | 06/05/13 | San Diego |
| Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting | Catherine Arnst | 12/07/12 | Boston |
| Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel | Luke Timmerman | 01/30/12 | Seattle |
| Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs | Arlene Weintraub | 01/26/12 | Boston |
| The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups | Luke Timmerman | 12/22/11 | Seattle |
| San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors | Bruce V. Bigelow | 04/27/11 | San Diego |
| HemaQuest Pockets Full $12M to Treat Sickle Cell and Other Blood Disorders | Luke Timmerman | 04/21/10 | Seattle |
| Paul Allen Diagnosed with Cancer | Luke Timmerman & Gregory T. Huang | 11/16/09 | Seattle |
| Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News | Luke Timmerman | 10/08/09 | Seattle |
| Seattle Genetics Shares Drop on Halted Lymphoma Trial | Luke Timmerman | 10/05/09 | Seattle |
| Genzyme’s Mozobil Gets European Approval | Ryan McBride | 08/05/09 | Boston |
| Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants | Ryan McBride | 05/27/09 | San Diego |
| Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009 | Luke Timmerman | 04/01/09 | San Diego |
| Cell Therapeutics Reports Severe Cardiac Events in Drug Trial | Luke Timmerman | 03/16/09 | Seattle |
| Seattle Genetics Gets Orphan Drug Status | Luke Timmerman | 01/26/09 | Seattle |
| Genzyme Wins FDA Approval of Mozobil | Luke Timmerman | 12/15/08 | Boston |
| Blood News: A Quick Rundown of Headlines From the American Society of Hematology | Luke Timmerman | 12/09/08 | National |
| Gloucester Drug Shrinks Tumors in Lymphoma Study | Luke Timmerman | 12/08/08 | Boston |
| Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting | Luke Timmerman | 12/06/08 | Seattle |
| Zevalin Gets 6-Month FDA Review | Luke Timmerman | 12/01/08 | Seattle |
| Cell Therapeutics, Spectrum Form Joint Venture | Gregory T. Huang | 11/26/08 | Seattle |
| Cell Therapeutics Lymphoma Drug Wipes Out Tumors in Pivotal Trial | Luke Timmerman | 11/11/08 | Seattle |
| Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal | Luke Timmerman | 10/16/08 | Seattle |
| Cell Therapeutics To File for FDA Approval of Zevalin In First-Line Lymphoma | Luke Timmerman | 09/22/08 | Seattle |
| Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche | Luke Timmerman | 07/22/08 | Boston |
